Acumen Stock Future Price Prediction

ABOS
 Stock
  

USD 5.68  0.16  2.74%   

Acumen Pharmaceuticals stock price prediction is an act of determining the future value of Acumen Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Acumen Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Acumen Pharmaceuticals and does not consider all of the tangible or intangible factors available from Acumen Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Acumen Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Please continue to Acumen Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Acumen Pharmaceuticals based on different types of headlines from major news networks to social media. The Acumen stock price prediction module provides an analysis of price elasticity to changes in media outlook on Acumen Pharmaceuticals over a specific investment horizon.
EPS Estimate Next Quarter
(0.25) 
EPS Estimate Current Year
(0.98) 
EPS Estimate Next Year
(1.18) 
Wall Street Target Price
15.83
EPS Estimate Current Quarter
(0.23) 
Using Acumen Pharmaceuticals hype-based prediction, you can estimate the value of Acumen Pharmaceuticals from the perspective of Acumen Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Acumen Pharmaceuticals using Acumen Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Acumen using crowd psychology based on the activity and movement of Acumen Pharmaceuticals' stock price.

Acumen Pharmaceuticals Implied Volatility

    
  80.95  
Acumen Pharmaceuticals' implied volatility exposes the market's sentiment of Acumen Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Acumen Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Acumen Pharmaceuticals stock will not fluctuate a lot when Acumen Pharmaceuticals' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Acumen Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Acumen Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Acumen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Acumen Pharmaceuticals after-hype prediction price

    
  $ 5.74  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Acumen Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Acumen Pharmaceuticals in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
1.469.9718.48
Details
3 Analysts
Consensus
LowTarget PriceHigh
16.0023.3327.00
Details
Earnings
Estimates (2)
LowProjected EPSHigh
-3.77-3.13-2.49
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Acumen Pharmaceuticals. Your research has to be compared to or analyzed against Acumen Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Acumen Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Acumen Pharmaceuticals.

Acumen Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Acumen Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Acumen Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Acumen Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Acumen Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Acumen Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Acumen Pharmaceuticals' historical news coverage. Acumen Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.29 and 14.25, respectively. We have considered Acumen Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 5.68
5.74
After-hype Price
14.25
Upside
Acumen Pharmaceuticals is relatively risky asset. Analysis and calculation of next after-hype price of Acumen Pharmaceuticals is based on 3 months time horizon.

Acumen Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Acumen Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Acumen Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Acumen Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.52  14.00  0.14    3.15  4 Events / Month1 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
5.685.741.06 
5,385  

Acumen Pharmaceuticals Hype Timeline

Acumen Pharmaceuticals is presently traded for 5.68. The entity has historical hype elasticity of 0.14 and average elasticity to hype of competition of -3.15. Acumen is estimated to increase in value after the next headline with the price projected to jump to 5.74 or above. The average volatility of media hype impact on the company stock price is over 100%. The price gain on the next news is forecasted to be 1.06% whereas the daily expected return is presently at 0.52%. The volatility of related hype on Acumen Pharmaceuticals is about 230.77% with expected price after next announcement by competition of 2.53. The company reported the previous year's revenue of 329 K. Net Loss for the year was (31.53 M) with loss before overhead, payroll, taxes, and interest of (12.3 M). Given the investment horizon of 90 days the next estimated press release will be in about 4 days.
Please continue to Acumen Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Acumen Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Acumen Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Acumen Pharmaceuticals' future price movements. Getting to know how Acumen Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Acumen Pharmaceuticals may potentially react to the hype associated with one of its peers.

Acumen Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Acumen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Acumen using various technical indicators. When you analyze Acumen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Acumen Pharmaceuticals Predictive Indicators

The successful prediction of Acumen Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Acumen Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Acumen Pharmaceuticals based on analysis of Acumen Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Acumen Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Acumen Pharmaceuticals's related companies.

Story Coverage note for Acumen Pharmaceuticals

The number of cover stories for Acumen Pharmaceuticals depends on current market conditions and Acumen Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Acumen Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Acumen Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Acumen Pharmaceuticals Short Properties

Acumen Pharmaceuticals' future price predictability will typically decrease when Acumen Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Acumen Pharmaceuticals often depends not only on the future outlook of the potential Acumen Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acumen Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out3.28%
Short Percent Of Float4.37%
Float Shares13.69M
Shares Short Prior Month697.96k
Average Daily Volume Last 10 Day129.89k
Average Daily Volume In Three Month1.4M
Date Short Interest14th of October 2022
Please continue to Acumen Pharmaceuticals Basic Forecasting Models to cross-verify your projections. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for analysis

When running Acumen Pharmaceuticals price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is Acumen Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acumen Pharmaceuticals. If investors know Acumen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acumen Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
239 M
Return On Assets
(0.11) 
Return On Equity
(0.18) 
The market value of Acumen Pharmaceuticals is measured differently than its book value, which is the value of Acumen that is recorded on the company's balance sheet. Investors also form their own opinion of Acumen Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Acumen Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acumen Pharmaceuticals' market value can be influenced by many factors that don't directly affect Acumen Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acumen Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Acumen Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acumen Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.